0000899243-21-028335.txt : 20210714 0000899243-21-028335.hdr.sgml : 20210714 20210714171840 ACCESSION NUMBER: 0000899243-21-028335 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210714 DATE AS OF CHANGE: 20210714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lloyd George W. CENTRAL INDEX KEY: 0001814899 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 211090917 MAIL ADDRESS: STREET 1: C/O ROYALTY PHARMA PLC STREET 2: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-12 0 0001802768 Royalty Pharma plc RPRX 0001814899 Lloyd George W. C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022 0 1 0 0 EVP, Investments & GC Class A Ordinary Shares 2021-07-12 4 S 0 100 42.04 D 806430 I By GWL 2014 G, LLC Class A Ordinary Shares 2021-07-13 4 S 0 5068 42.0067 D 600773 I By GWL 2013 NG, LLC Class A Ordinary Shares 2021-07-13 4 S 0 17981 42.0089 D 788449 I By GWL 2014 G, LLC Class A Ordinary Shares 240000 I By GWL 2020 G, LLC Class A Ordinary Shares 3000 D Class A Ordinary Shares 273960 I By IRA Class A Ordinary Shares 4000 I By Spouse The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. All reported transactions were effected pursuant to 10b5-1 plans adopted by the reporting person on December 28, 2020. /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd 2021-07-14